Blood Collection Devices Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028
Blood Collection Devices Market |
Devices for collecting blood are essential to patient care. Blood samples are taken to assess the basic metabolic elements, including blood urea nitrogen, sodium, potassium, creatinine, magnesium, and chloride, as well as blood glucose and lipid levels, as part of the treatment. The availability and sophistication of technology have grown in recent years, presenting a wide range of opportunities and difficulties for laboratory professionals.
The Blood
Collection Devices Market is expanding as a result of the rising
incidence of certain diseases like cancer, HIV/AIDS, diabetes, coronary heart
disease, and anaemia. The Blood Collection Devices Market is also expanding as a result
of rising surgical rates, a high demand for blood transfusions, and casualty
situations. The United States reported 26,203 cases of Lyme disease between
2006 and 2016, according to the Centers for Disease Control and Prevention
(CDC). The same source estimates that 10,265 deaths—or about 29% of all
traffic-related deaths in the United States—were reported in 2015 as a result
of alcohol-impaired collisions.
When given the chance,
technologists can perform a wider range of tests on smaller samples with higher
levels of accuracy than they could with a manual blood collection procedure. As
a result, more and more laboratories are moving away from manual platforms and
toward automated haematology and chemical analyzers. Additionally, the market
for blood collection devices is being driven by the rising demand for blood
donations.
For instance, the World Health
Organization (WHO) reports that 112.5 million units of blood were donated
worldwide in 2013, an increase of 10.7 million units from unpaid donors from
2008. Additionally, the American National Red Cross reports that nearly 21
million blood components are transfused in the U.S. annually, with a daily
requirement of roughly 7,000 units of platelets and 10,000 units of plasma.
Major Companies Involved are- Becton, Dickinson and Company, NIPRO Medical Corporation, Terumo Medical Corporation, Medtronic plc, Qiagen, Bio-Rad Laboratories, Inc., Haemonetics Corporation, and Fresenius SE & Co. KGaA.
Comments
Post a Comment